Alanylglutamine is a nutritional supplement containing a stable, water-soluble dipeptide comprised of the amino acids L-glutamine and L-alanine, with potential protective and absorption enhancing activities.
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
| Synonyms/Alias | l-Alanyl-l-glutamine;39537-23-0;Ala-gln;alanylglutamine;Alanyl-glutamine;alanyl glutamine;Dipeptamin;GlutaMAX;Sustamine;L-Glutamine, L-alanyl-;N(2)-L-Alanyl-L-glutamine;Dipeptiven;L-Ala-L-Gln;Glutamax I;H-Ala-Gln-OH;l-alanine-l-glutamine;Alanyl-glutamine dipeptide;Dipeptide Alanyl-Glutamine;L-Glutamine, N2-L-alanyl-;U5JDO2770Z;L-alanyl-l-glutamine amino acid;FEMA NO. 4712;N(2)-L-Alanine L-Glutamine dipeptide;CHEBI:73788;GLUTAMINE, N2-L-ALANYL-;DTXSID20192658;ALANYL GLUTAMINE [WHO-DD];(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoic acid;L-ALANYL-L-GLUTAMINE [USP-RS];(S)-5-amino-2-((S)-2-aminopropanamido)-5-oxopentanoic acid;(2S)-5-Amino-2-(((2S)-2-aminopropanoyl)amino)-5-oxopentanoic acid;(2S)-5-amino-2-{[(2S)-2-aminopropanoyl]amino}-5-oxopentanoic acid;MFCD00133046;L-ALANYL-L-GLUTAMINE (USP-RS);L-Alany-L-glutamine;UNII-U5JDO2770Z;AlaGln;AQ dipeptide;LAlanylLglutamine;L-Alanyl-L-glutamine 1-hydrate;A-Q Dipeptide;LGlutamine, Lalanyl;(2S)-5-amino-2-{[(2S)-2-azaniumylpropanoyl]amino}-5-oxopentanoate;L-alanyl/L-glutamine;-5-oxopentanoic acid;LGlutamine, N2Lalanyl;N(2)LAlanylLglutamine;Alanine Glutamine dipeptide;Alanine-Glutamine dipeptide;210541-56-3;L-Ala-Gln, for cell culture;SCHEMBL133887;ALANYL GLUTAMINE [INCI];CHEMBL3707366;DTXCID60115149;L-Alanyl-L-glutamine (Standard);Ala-Gln, >=98% (TLC);BDBM627986;HY-W014102R;N(2)-L-Alanyl-L-Glutamine,(S);N(2)-L-ALANYL-LEVOGLUTAMIDE;s5801;AKOS010366801;(2S)5Amino2(amino)5oxopentanoic acid;CS-W014818;DB11876;FA29476;HY-W014102;CVD-0019434;L-Alanyl-L-glutamine, for cell culture;AS-12601;(S)-5-amino-2-((S)-2-aminopropanamido);DB-030066;A1261;NS00006426;BRD-K11595419-001-01-4;Q27144111;(S)-5-amino-2-((S)-2-aminopropanamido)-5-oxopentanoicacid;L-Alanyl-L-glutamine, United States Pharmacopeia (USP) Reference Standard;Ala-Gln, BioReagent, suitable for cell culture, suitable for insect cell culture;475-290-9;609-717-9; |
| M.F/Formula | C8H15N3O4 |
| M.W/Mr. | 217.22 |
| Sequence | One Letter Code:AQ Three Letter Code:H-Ala-Gln-OH |
| INCIName | ALANYL GLUTAMINE |
| InChI | InChI=1S/C8H15N3O4/c1-4(9)7(13)11-5(8(14)15)2-3-6(10)12/h4-5H,2-3,9H2,1H3,(H2,10,12)(H,11,13)(H,14,15)/t4-,5-/m0/s1 |
| InChI Key | HJCMDXDYPOUFDY-WHFBIAKZSA-N |
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.